Our study indicates the methylation status of regulators of the p53-Bax mitochondrial apoptosis pathway could indicate the biological behavior of cholangiocarcinoma and predict prognosis of these patients, providing a basis for postoperative adjunctive treatment [16]. The gene discussed is BAX; the disease is cholangiocarcinoma.